Esophageal Diseases D004935

Diseases [C] » Digestive System Diseases [C06] » Gastrointestinal Diseases » Esophageal Diseases

Description

Pathological processes in the ESOPHAGUS.   MeSH

Subtype Terms (11)

Barrett Esophagus
36 drugs (23 approved, 13 experimental)

Deglutition Disorders
63 drugs (42 approved, 21 experimental)

Diverticulosis, Esophageal
 

Esophageal and Gastric Varices
62 drugs (40 approved, 22 experimental)

Esophageal Atresia
5 approved drugs

Esophageal Cyst
 

Esophageal Fistula
1 experimental drug

Esophageal Neoplasms
633 drugs (210 approved, 423 experimental)

Esophageal Perforation
 

Esophageal Stenosis
7 approved drugs

Esophagitis
36 drugs (20 approved, 16 experimental)



Organization Involved with Phase 3 Indications (3)

Organization Involved with Phase 1 Indications (2)

Organization Involved with Other Experimental Indications (2)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.